Henry ScheinHSIC
HSIC
0
Funds holding %
of 7,372 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
216% more call options, than puts
Call options by funds: $13.8M | Put options by funds: $4.37M
37% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 51
25% more funds holding in top 10
Funds holding in top 10: 8 [Q3] → 10 (+2) [Q4]
2% more funds holding
Funds holding: 524 [Q3] → 533 (+9) [Q4]
4.07% less ownership
Funds ownership: 106.67% [Q3] → 102.6% (-4.07%) [Q4]
10% less capital invested
Capital invested by funds: $9.85B [Q3] → $8.85B (-$996M) [Q4]
18% less repeat investments, than reductions
Existing positions increased: 170 | Existing positions reduced: 208
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$80
13%
upside
Avg. target
$83
17%
upside
High target
$90
27%
upside
5 analyst ratings
2 positive
40%
3 neutral
60%
0 negative
0%
UBS Kevin Caliendo 57% 1-year accuracy 8 / 14 met price target | 13%upside $80 | Neutral Maintained | 26 Feb 2025 |
Barrington Research Michael Petusky 36% 1-year accuracy 26 / 73 met price target | 27%upside $90 | Outperform Maintained | 26 Feb 2025 |
Wells Fargo Vik Chopra 33% 1-year accuracy 4 / 12 met price target | 13%upside $80 | Equal-Weight Initiated | 14 Feb 2025 |
Jefferies Brandon Couillard 19% 1-year accuracy 4 / 21 met price target | 13%upside $80 | Hold Maintained | 23 Jan 2025 |
B of A Securities Michael Cherny 68% 1-year accuracy 19 / 28 met price target | 19%upside $84 | Buy Upgraded | 6 Jan 2025 |
Financial journalist opinion
Based on 13 articles about HSIC published over the past 30 days
Neutral
Business Wire
1 week ago
Ethisphere Names Henry Schein as One of the 2025 World's Most Ethical Companies® for 14th Consecutive Year
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, has received the 2025 World's Most Ethical Companies® recognition by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. Recognized since 2012, Henry Schein is one of three honorees in the Healthcare Products industry. In 2025, 136 honorees were recognized, spanning 19 countries.
Positive
Seeking Alpha
1 week ago
Henry Schein Looks Bullish (Technical Analysis)
HSIC shows bullish price action, momentum, volume, and relative strength, making it an attractive investment with a 2.6 reward-to-risk ratio. The stock is in an uptrend, trading above its 30-week EMA, and has bullish short-term and long-term momentum as indicated by the PPO. Institutional buying supports bullish volume trends, and HSIC has been outperforming the S&P 500 since December 2024.
Positive
Seeking Alpha
2 weeks ago
Henry Schein: An Industry Leader That Offers Some Upside From Here
Henry Schein is the world's largest provider of healthcare products and services for office-based dental and medical practitioners, showing consistent growth through acquisitions. Despite a 3% dip in shares, management's 2025 guidance indicates continued growth, justifying a bullish stance on the stock. The firm reported a 5.8% revenue increase in Q4 2024, driven by organic growth and acquisitions, with significant improvements in net income and operating cash flow.
Neutral
Business Wire
2 weeks ago
Henry Schein to Participate in Upcoming Investor Conference in March
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the Leerink Global Healthcare Conference on Tuesday, March 11th, 2025, at the W South Beach hotel in Miami at 1:40 p.m. Eastern time. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Sc.
Neutral
Business Wire
3 weeks ago
Nominations Now Open for Henry Schein Medical's Athletics and Schools 2025 Rising Star Award
MELVILLE, N.Y.--(BUSINESS WIRE)--In celebration of National Athletic Training Month in March, Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is now accepting nominations for its Henry Schein Medical Athletics and Schools 2025 Rising Star Award. Created in 2021, the annual Award honors emerging athletic trainers who have one to five years of experience in the sports medicine profession. It recognizes recently graduated athletic trainers in the United States.
Neutral
Seeking Alpha
3 weeks ago
Henry Schein, Inc. (HSIC) Q4 2024 Earnings Call Transcript
Henry Schein, Inc. (NASDAQ:HSIC ) Q4 2024 Earnings Conference Call February 25, 2025 8:00 AM ET Company Participants Graham Stanley - Vice President of Investor Relations & Strategic Financial Project Officer Stanley Bergman - Chairman & Chief Executive Officer Ronald South - Senior Vice President & Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Jeffrey Johnson - Baird Allen Lutz - Bank of America John Stansel - JPMorgan Jonathan Block - Stifel Kevin Caliendo - UBS Brandon Vazquez - William Blair Elizabeth Anderson - Evercore ISI Operator Good morning ladies and gentlemen and welcome to Henry Schein's Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Positive
Zacks Investment Research
3 weeks ago
HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket
Henry Schein's fourth-quarter results reflect stable dental and medical end-markets.
Negative
Benzinga
3 weeks ago
Henry Schein Q4 Earnings And Outlook Miss Expectations, Restructures For Growth
On Tuesday, Henry Schein Inc. HSIC reported a fourth-quarter adjusted EPS of $1.19, up 80.3% year-over-year, missing the consensus of $1.21.
Positive
Zacks Investment Research
3 weeks ago
Henry Schein (HSIC) Meets Q4 Earnings Estimates
Henry Schein (HSIC) came out with quarterly earnings of $1.19 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.66 per share a year ago.
Negative
Reuters
3 weeks ago
Henry Schein forecasts 2025 profit below estimates on weak demand for dental products
Henry Schein forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid persistent inflation.
Charts implemented using Lightweight Charts™